{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:52:31Z","timestamp":1786114351410,"version":"build-2736575974"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21AI180822"],"award-info":[{"award-number":["R21AI180822"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009240","name":"Sveriges Kommuner och Landsting","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009240","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Biomaterialia"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.actbio.2026.04.023","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T16:39:53Z","timestamp":1776443993000},"page":"406-416","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Enhancing in vivo B cell gene delivery using targeted lentiviral vectors and transduction enhancers"],"prefix":"10.1016","volume":"218","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5191-1582","authenticated-orcid":false,"given":"Marshall","family":"Fritz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limei","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas C.","family":"Olson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madison","family":"Card","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Pickles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4721-528X","authenticated-orcid":false,"given":"Samuel K.","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.actbio.2026.04.023_bib0001","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.cell.2019.03.016","article-title":"B cell responses: cell interaction dynamics and decisions","volume":"177","author":"Cyster","year":"2019","journal-title":"Cell"},{"issue":"7212","key":"10.1016\/j.actbio.2026.04.023_bib0002","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/nature07231","article-title":"Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors","volume":"455","author":"Yu","year":"2008","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.actbio.2026.04.023_bib0003","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1111\/jth.13520","article-title":"Baboon envelope pseudotyped lentiviral vectors efficiently transduce human B cells and allow active factor IX B cell secretion in vivo in NOD\/SCID\u03b3c-\/- mice","volume":"14","author":"Levy","year":"2016","journal-title":"J. Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.actbio.2026.04.023_bib0004","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nm.2071","article-title":"Generation of stable monoclonal antibody\u2013producing B cell receptor\u2013positive human memory B cells by genetic programming","volume":"16","author":"Kwakkenbos","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.actbio.2026.04.023_bib0005","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.3389\/fimmu.2019.02630","article-title":"Molecular design, optimization, and genomic integration of chimeric B cell receptors in murine B cells","volume":"10","author":"Pesch","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.actbio.2026.04.023_bib0006","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.omtm.2017.03.005","article-title":"Immune modulatory cell therapy for hemophilia B based on CD20-targeted lentiviral gene transfer to primary B cells","volume":"5","author":"Wang","year":"2017","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.actbio.2026.04.023_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115285","article-title":"Challenges and opportunities in gene editing of B cells","volume":"206","author":"Edelstein","year":"2022","journal-title":"Biochem. Pharmacol"},{"issue":"19","key":"10.1016\/j.actbio.2026.04.023_bib0008","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph191912366","article-title":"Price and prejudice? The value of chimeric antigen receptor (CAR) T-cell therapy","volume":"19","author":"Choi","year":"2022","journal-title":"Int J. Environ. Res. Public Health"},{"issue":"10","key":"10.1016\/j.actbio.2026.04.023_bib0009","doi-asserted-by":"crossref","first-page":"4163","DOI":"10.4049\/jimmunol.1502193","article-title":"Efficient culture of Human naive and memory B cells for use as APCs","volume":"197","author":"Su","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.actbio.2026.04.023_bib0010","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.omtm.2018.10.006","article-title":"Surface-engineered lentiviral vectors for selective gene transfer into subtypes of lymphocytes","volume":"12","author":"Frank","year":"2019","journal-title":"Mol. Ther. Methods Clin. Dev."},{"issue":"9","key":"10.1016\/j.actbio.2026.04.023_bib0011","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1182\/blood-2013-11-540641","article-title":"Mystery solved: VSV-G-LVs do not allow efficient gene transfer into unstimulated T cells, B cells, and HSCs because they lack the LDL receptor","volume":"123","author":"Amirache","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.actbio.2026.04.023_bib0012","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.3389\/fimmu.2022.892169","article-title":"The ins and outs of antigen uptake in B cells","volume":"13","author":"McShane","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.actbio.2026.04.023_bib0013","series-title":"Molecular Mechanisms of Measles Virus Entry and Exit","author":"Carneiro","year":"2016"},{"issue":"6","key":"10.1016\/j.actbio.2026.04.023_bib0014","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005641","article-title":"Receptor-targeted Nipah virus glycoproteins improve cell-type selective gene delivery and reveal a preference for membrane-proximal cell attachment","volume":"12","author":"Bender","year":"2016","journal-title":"PLoS Pathog"},{"issue":"8","key":"10.1016\/j.actbio.2026.04.023_bib0015","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1038\/mt.2008.128","article-title":"Targeted cell entry of lentiviral vectors","volume":"16","author":"Funke","year":"2008","journal-title":"Mol. Ther."},{"issue":"5","key":"10.1016\/j.actbio.2026.04.023_bib0016","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.tibtech.2009.02.002","article-title":"Lentiviral vectors with measles virus glycoproteins \u2013 dream team for gene transfer?","volume":"27","author":"Buchholz","year":"2009","journal-title":"Trends Biotechnol."},{"issue":"5","key":"10.1016\/j.actbio.2026.04.023_bib0017","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1016\/j.jcyt.2019.04.044","article-title":"Protransduzin\u2122 - A novel transduction enhancer to accelerate en gros CAR-T production","volume":"21","author":"Castro","year":"2019","journal-title":"Cytotherapy"},{"issue":"6","key":"10.1016\/j.actbio.2026.04.023_bib0018","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1007\/s10238-022-00928-8","article-title":"Effects of polybrene and retronectin as transduction enhancers on the development and phenotypic characteristics of VHH-based CD19-redirected CAR T cells: a comparative investigation","volume":"23","author":"Nasiri","year":"2023","journal-title":"Clin. Exp. Med."},{"issue":"2","key":"10.1016\/j.actbio.2026.04.023_bib0019","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1053\/j.seminhematol.2020.07.005","article-title":"Improving CAR T cell therapy by optimizing critical quality attributes","volume":"57","author":"Reddy","year":"2020","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.actbio.2026.04.023_bib0020","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/978-1-4939-3753-0_4","article-title":"Optimized lentiviral transduction protocols by use of a poloxamer enhancer, spinoculation, and scFv-antibody fusions to VSV-G","volume":"1448","author":"Anastasov","year":"2016","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.actbio.2026.04.023_bib0021","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.omtm.2019.01.005","article-title":"High-efficiency lentiviral transduction of Human CD34+ cells in High-density culture with poloxamer and prostaglandin E2","volume":"13","author":"Uchida","year":"2019","journal-title":"Mol. Ther. Methods Clin. Dev."},{"issue":"12","key":"10.1016\/j.actbio.2026.04.023_bib0022","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1089\/hum.2019.157","article-title":"Vectofusin-1 improves transduction of primary Human cells with diverse retroviral and lentiviral pseudotypes, enabling robust, automated closed-system manufacturing","volume":"30","author":"Radek","year":"2019","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.actbio.2026.04.023_bib0023","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.actbio.2017.10.009","article-title":"Vectofusin-1, a potent peptidic enhancer of viral gene transfer forms pH-dependent \u03b1-helical nanofibrils, concentrating viral particles","volume":"64","author":"Vermeer","year":"2017","journal-title":"Acta Biomater."},{"key":"10.1016\/j.actbio.2026.04.023_bib0024","doi-asserted-by":"crossref","first-page":"e90","DOI":"10.1038\/mtna.2013.17","article-title":"Vectofusin-1, a new viral entry enhancer, strongly promotes lentiviral transduction of Human hematopoietic stem cells","volume":"2","author":"Fenard","year":"2013","journal-title":"Mol. Ther. - Nucleic Acids"},{"issue":"8","key":"10.1016\/j.actbio.2026.04.023_bib0025","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1089\/hum.2019.009","article-title":"Constraints on Human CD34+ cell fate due to lentiviral vectors can Be relieved by valproic acid","volume":"30","author":"Moussy","year":"2019","journal-title":"Hum. Gene Ther."},{"issue":"6","key":"10.1016\/j.actbio.2026.04.023_bib0026","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/j.jaci.2013.01.018","article-title":"Inhibition of human B-cell development into plasmablasts by histone deacetylase inhibitor valproic acid","volume":"131","author":"Kienzler","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"issue":"6","key":"10.1016\/j.actbio.2026.04.023_bib0027","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1182\/blood-2013-12-546218","article-title":"Rapamycin relieves lentiviral vector transduction resistance in human and mouse hematopoietic stem cells","volume":"124","author":"Wang","year":"2014","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.actbio.2026.04.023_bib0028","doi-asserted-by":"crossref","first-page":"8463","DOI":"10.1128\/JVI.72.11.8463-8471.1998","article-title":"A third-generation lentivirus vector with a conditional packaging system","volume":"72","author":"Dull","year":"1998","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.actbio.2026.04.023_bib0029","doi-asserted-by":"crossref","first-page":"e125","DOI":"10.1002\/cpmb.125","article-title":"Optimized transgene delivery using third-generation lentiviruses","volume":"133","author":"Gill","year":"2020","journal-title":"Curr. Protoc. Mol. Biol."},{"issue":"1","key":"10.1016\/j.actbio.2026.04.023_bib0030","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1038\/s41598-017-02460-2","article-title":"Systematic comparison of 2A peptides for cloning multi-genes in a polycistronic vector","volume":"7","author":"Liu","year":"2017","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.actbio.2026.04.023_bib0031","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1080\/21645515.2020.1748979","article-title":"Active immunoprophylaxis with a synthetic DNA-encoded monoclonal anti-respiratory syncytial virus scFv-fc fusion protein confers protection against infection and durable activity","volume":"16","author":"Schultheis","year":"2020","journal-title":"Hum. Vaccin Immunother."},{"key":"10.1016\/j.actbio.2026.04.023_bib0032","author":"River","year":"2011","journal-title":"NODSCID Mouse Clin. Pathol. Data"},{"issue":"1","key":"10.1016\/j.actbio.2026.04.023_bib0033","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-30358-0","article-title":"Engineering of primary Human B cells with CRISPR\/Cas9 targeted nuclease","volume":"8","author":"Johnson","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.actbio.2026.04.023_bib0034","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.42995","article-title":"Reprogramming the antigen specificity of B cells using genome-editing technologies","volume":"8","author":"Voss","year":"2019","journal-title":"eLife"},{"issue":"8","key":"10.1016\/j.actbio.2026.04.023_bib0035","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1038\/s41587-022-01328-9","article-title":"In vivo engineered B cells secrete high titers of broadly neutralizing anti-HIV antibodies in mice","volume":"40","author":"Nahmad","year":"2022","journal-title":"Nat. Biotechnol."},{"issue":"35","key":"10.1016\/j.actbio.2026.04.023_bib0036","doi-asserted-by":"crossref","first-page":"eaax0644","DOI":"10.1126\/sciimmunol.aax0644","article-title":"B cells engineered to express pathogen-specific antibodies protect against infection","volume":"4","author":"Moffett","year":"2019","journal-title":"Sci. Immunol."},{"issue":"5","key":"10.1016\/j.actbio.2026.04.023_bib0037","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0958-1669(98)80029-3","article-title":"Lentiviruses as gene transfer agents for delivery to non-dividing cells","volume":"9","author":"Naldini","year":"1998","journal-title":"Curr. Opin. Biotechnol."},{"issue":"9","key":"10.1016\/j.actbio.2026.04.023_bib0038","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/nri2155","article-title":"FcRn: the neonatal fc receptor comes of age","volume":"7","author":"Roopenian","year":"2007","journal-title":"Nat. Rev. Immunol."},{"issue":"11","key":"10.1016\/j.actbio.2026.04.023_bib0039","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0079047","article-title":"CD19 and CD20 targeted vectors induce minimal activation of resting B lymphocytes","volume":"8","author":"Kneissl","year":"2013","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.actbio.2026.04.023_bib0040","doi-asserted-by":"crossref","first-page":"e77","DOI":"10.1002\/cpph.77","article-title":"Establishment of humanized mice from peripheral blood mononuclear cells or cord blood CD34+ hematopoietic stem cells for immune-oncology studies evaluating new therapeutic agents","volume":"89","author":"Verma","year":"2020","journal-title":"Curr. Protoc. Pharmacol."},{"issue":"7","key":"10.1016\/j.actbio.2026.04.023_bib0041","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.3390\/cancers12071915","article-title":"Humanized mice are precious tools for preclinical evaluation of CAR T and CAR NK cell therapies","volume":"12","author":"Mhaidly","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"11","key":"10.1016\/j.actbio.2026.04.023_bib0042","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1158\/1078-0432.CCR-20-2540","article-title":"Preclinical evaluation of B7-H3\u2013specific chimeric antigen receptor T cells for the treatment of acute myeloid leukemia","volume":"27","author":"Lichtman","year":"2021","journal-title":"Clin. Cancer Res."},{"issue":"9","key":"10.1016\/j.actbio.2026.04.023_bib0043","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-002737","article-title":"Bispecific binder redirected lentiviral vector enables in vivo engineering of CAR-T cells","volume":"9","author":"Huckaby","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.actbio.2026.04.023_bib0044","unstructured":"Inactive ingredients database download, (2026)."},{"key":"10.1016\/j.actbio.2026.04.023_bib0045","series-title":"StatPearls [Internet]","article-title":"Valproic acid","author":"Rahman","year":"2024"},{"issue":"7","key":"10.1016\/j.actbio.2026.04.023_bib0046","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1089\/hum.2013.211","article-title":"Dissecting the mechanism of histone deacetylase inhibitors to enhance the activity of zinc finger nucleases delivered by integrase-defective lentiviral vectors","volume":"25","author":"Joglekar","year":"2014","journal-title":"Hum. Gene Ther."},{"issue":"9","key":"10.1016\/j.actbio.2026.04.023_bib0047","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2018.1479627","article-title":"Clinically-relevant rapamycin treatment regimens enhance CD8+ effector memory T cell function In the skin and allow their infiltration into cutaneous squamous cell carcinoma","volume":"7","author":"Jung","year":"2018","journal-title":"OncoImmunology"},{"key":"10.1016\/j.actbio.2026.04.023_bib0048","doi-asserted-by":"crossref","DOI":"10.1007\/s11357-025-01911-3","article-title":"Pharmacokinetic analysis of intermittent rapamycin administration in early-stage Alzheimer's Disease","author":"Wallgren","year":"2025","journal-title":"GeroScience"},{"issue":"1","key":"10.1016\/j.actbio.2026.04.023_bib0049","doi-asserted-by":"crossref","first-page":"65","DOI":"10.18433\/J37G7M","article-title":"The single dose poloxamer 407 model of hyperlipidemia; systemic effects on lipids assessed using pharmacokinetic methods, and its effects on adipokines","volume":"16","author":"Chaudhary","year":"2013","journal-title":"J. Pharm. Pharm. Sci."}],"container-title":["Acta Biomaterialia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706126002424?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706126002424?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T20:48:29Z","timestamp":1785962909000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1742706126002424"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":49,"alternative-id":["S1742706126002424"],"URL":"https:\/\/doi.org\/10.1016\/j.actbio.2026.04.023","relation":{},"ISSN":["1742-7061"],"issn-type":[{"value":"1742-7061","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhancing in vivo B cell gene delivery using targeted lentiviral vectors and transduction enhancers","name":"articletitle","label":"Article Title"},{"value":"Acta Biomaterialia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actbio.2026.04.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc. on behalf of Acta Materialia Inc.","name":"copyright","label":"Copyright"}]}}